Consultation on the projected impact and cost effectiveness of long-acting injectable Lenacapavir as PreExposure Prophylaxis

27/09/2025

What can modelling tell us about the scale-up of lenacapavir for pre-exposure prophylaxis?

27/09/2025

PrEP target-setting for key and high-priority populations – Estimating the number at risk

19/01/2022

Oral pre-exposure prophylaxis (PrEP) is recommended by the World Health Organization (WHO) as an additional prevention option for people at substantial risk for HIV infection as part of combination HIV prevention. Providing access to PrEP is one of the five prevention pillars to meet global targets to reduce the number of new HIV infections by […]

PrEP target-setting for key and high-priority populations – Technical materials

19/01/2022

PrEP target-setting for key and high-priority populations – Technical materials

PrEP target-setting for key and high-priority populations – Using the tools

19/01/2022

PrEP target-setting for key and high-priority populations – Using the tools

PrEP target-setting tools

19/01/2022

PrEP target-setting tools

PrEP example spreadsheets

19/01/2022

PrEP example spreadsheets